GetTopicDetailResponse(id=d3be939563c, topicName=達(dá)肝素鈉, introduction=達(dá)肝素鈉, content=null, image=null, comments=3, allHits=731, url=https://h5.medsci.cn/topic?id=93956, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=89907, tagList=[TagDto(tagId=89907, tagName=達(dá)肝素鈉)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1813862, encodeId=eca8181386248, content=<a href='/topic/show?id=d3be939563c' target=_blank style='color:#2F92EE;'>#達(dá)肝素鈉#</a>, objectTitle=JAHA：磺達(dá)肝素鈉與低分子量肝素在圍手術(shù)期血栓預(yù)防的療效比較, objectType=article, longId=166177, objectId=ae1a1661e713, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae1a1661e713, replyNumber=0, likeNumber=70, createdTime=2020-01-01, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae1a1661e713, moduleTitle=JAHA：磺達(dá)肝素鈉與低分子量肝素在圍手術(shù)期血栓預(yù)防的療效比較, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ae1a1661e713)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813863, encodeId=69c91813863f0, content=<a href='/topic/show?id=d3be939563c' target=_blank style='color:#2F92EE;'>#達(dá)肝素鈉#</a>, objectTitle=FDA批準(zhǔn)Fragmin（達(dá)肝素鈉）作為兒童的第一個(gè)抗凝劑, objectType=article, longId=166317, objectId=d5d816631e72, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5d816631e72, replyNumber=0, likeNumber=88, createdTime=2019-06-02, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5d816631e72, moduleTitle=FDA批準(zhǔn)Fragmin（達(dá)肝素鈉）作為兒童的第一個(gè)抗凝劑, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d5d816631e72)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813864, encodeId=f34f181386442, content=<a href='/topic/show?id=d3be939563c' target=_blank style='color:#2F92EE;'>#達(dá)肝素鈉#</a>, objectTitle=兒童抗凝藥獲批！美FDA批準(zhǔn)達(dá)肝素鈉注射劑用于兒童, objectType=article, longId=166580, objectId=8eee16658030, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8eee16658030, replyNumber=0, likeNumber=81, createdTime=2020-03-24, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8eee16658030, moduleTitle=兒童抗凝藥獲批！美FDA批準(zhǔn)達(dá)肝素鈉注射劑用于兒童, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8eee16658030)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
